| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.87B | -2.2% |
| Cost of Revenue | $3.33B | -3.8% |
| Gross Profit | $531.0M | +9.0% |
| R&D Expense | $191.0M | -9.0% |
| SG&A Expense | $207.0M | +0.0% |
| Interest Expense | $15.0M | -11.8% |
| Pre-tax Income | $298.0M | +16.0% |
| Income Tax | $14.0M | +105.6% |
| Net Income | $274.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $623.0M | +21.0% |
| Accounts Receivable | $578.0M | -13.2% |
| Inventory | $283.0M | -5.0% |
| Current Assets | $1.60B | -1.2% |
| Total Assets | $2.86B | +5.0% |
| Current Liabilities | $916.0M | -1.6% |
| Long-term Debt | $301.0M | -5.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $427.0M | +59.9% |
| Investing Cash Flow | -$189.0M | -53.7% |
| Financing Cash Flow | -$100.0M | +35.9% |
| -43.6% |
| EPS (Basic) | $9.93 | -42.6% |
| EPS (Diluted) | $9.82 | -42.4% |
| Stockholders' Equity |
| $1.23B |
| +18.4% |